The poor translatability of early-stage preclinical models is a major setback in oncology drug development, and inter patient tumor heterogeneity is also a significant hurdle. Patient-derived ...

How to Improve Cancer Patients ENrollment in Clinical Trials From rEal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in ...

CPAM serves as a resource dedicated to helping UAB researchers understand genetic changes in disease by developing precision disease models that span experimental, cellular and computational systems. ...

The Center for Precision Medicine Models at Baylor College of Medicine accepts submissions from clinicians, genetic counselors, and researchers who seek to demonstrate the functional impact of a ...

Dr. Suruchi Kothari, BSc, MD, MRCGP, MSx: Health tech innovator reshaping clinical care. Driven by a tech-forward, patient-centric approach. Cancer's shadow stretches wider than ever, mirroring a ...